Mechanism of the mesenchymal-epithelial transition and its relationship with metastatic tumor formation
- PMID: 21840933
- DOI: 10.1158/1541-7786.MCR-10-0568
Mechanism of the mesenchymal-epithelial transition and its relationship with metastatic tumor formation
Abstract
Cancer metastasis consists of a sequential series of events, and the epithelial-mesenchymal transition (EMT) and mesenchymal-epithelial transition (MET) are recognized as critical events for metastasis of carcinomas. A current area of focus is the histopathological similarity between primary and metastatic tumors, and MET at sites of metastases has been postulated to be part of the process of metastatic tumor formation. Here, we summarize accumulating evidence from experimental studies that directly supports the role of MET in cancer metastasis, and we analyze the main mechanisms that regulate MET or reverse EMT in carcinomas. Given the critical role of MET in metastatic tumor formation, the potential to effectively target the MET process at sites of metastasis offers new hope for inhibiting metastatic tumor formation.
Similar articles
-
EMT as the ultimate survival mechanism of cancer cells.Semin Cancer Biol. 2012 Jun;22(3):194-207. doi: 10.1016/j.semcancer.2012.02.013. Epub 2012 Mar 8. Semin Cancer Biol. 2012. PMID: 22406545 Review.
-
Molecular Pathways Mediating Metastases to the Brain via Epithelial-to-Mesenchymal Transition: Genes, Proteins, and Functional Analysis.Anticancer Res. 2016 Feb;36(2):523-32. Anticancer Res. 2016. PMID: 26851006
-
Overexpression of miR-429 induces mesenchymal-to-epithelial transition (MET) in metastatic ovarian cancer cells.Gynecol Oncol. 2011 Apr;121(1):200-5. doi: 10.1016/j.ygyno.2010.12.339. Epub 2011 Jan 28. Gynecol Oncol. 2011. PMID: 21277012
-
Growth factors in induction of epithelial-mesenchymal transition and metastasis.Cells Tissues Organs. 2011;193(1-2):85-97. doi: 10.1159/000320360. Epub 2010 Nov 3. Cells Tissues Organs. 2011. PMID: 21051862 Review.
-
Concepts of metastasis in flux: the stromal progression model.Semin Cancer Biol. 2012 Jun;22(3):174-86. doi: 10.1016/j.semcancer.2012.02.007. Epub 2012 Feb 21. Semin Cancer Biol. 2012. PMID: 22374376 Review.
Cited by
-
SPRR2A expression in cholangiocarcinoma increases local tumor invasiveness but prevents metastasis.Clin Exp Metastasis. 2013 Oct;30(7):877-90. doi: 10.1007/s10585-013-9589-2. Epub 2013 Jun 1. Clin Exp Metastasis. 2013. PMID: 23728799
-
Downregulation of FOXO6 in breast cancer promotes epithelial-mesenchymal transition and facilitates migration and proliferation of cancer cells.Cancer Manag Res. 2018 Oct 30;10:5145-5156. doi: 10.2147/CMAR.S157661. eCollection 2018. Cancer Manag Res. 2018. PMID: 30464613 Free PMC article.
-
FGFR3 promotes the growth and malignancy of melanoma by influencing EMT and the phosphorylation of ERK, AKT, and EGFR.BMC Cancer. 2019 Oct 16;19(1):963. doi: 10.1186/s12885-019-6161-8. BMC Cancer. 2019. PMID: 31619201 Free PMC article.
-
The biology and clinical potential of circulating tumor cells.Radiol Oncol. 2019 May 8;53(2):131-147. doi: 10.2478/raon-2019-0024. Radiol Oncol. 2019. PMID: 31104002 Free PMC article. Review.
-
Epithelial mesenchymal transition status is associated with anti-cancer responses towards receptor tyrosine-kinase inhibition by dovitinib in human bladder cancer cells.BMC Cancer. 2013 Dec 11;13:589. doi: 10.1186/1471-2407-13-589. BMC Cancer. 2013. PMID: 24325461 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous